This question tests recognition of angioedema as a life-threatening adverse effect of ACE inhibitors and the need for immediate intervention. The client is experiencing classic signs of angioedema including swelling of the lips and tongue with hoarseness, which can rapidly progress to airway obstruction. Swelling of the lips and tongue with hoarseness (B) represents the most critical finding that requires immediate reporting as it indicates potential airway compromise. A mild dry cough (A) is a common side effect of ACE inhibitors that doesn't require immediate intervention. Blood pressure of 104/68 (C) after the first dose shows the medication is working but isn't dangerously low. Tachycardia after activity (D) is an expected physiological response. The principle of prioritization is that airway threats always take precedence over other concerns. A transferable strategy is to recognize that ACE inhibitor-induced angioedema can occur even after the first dose and requires immediate discontinuation of the medication and emergency treatment.

This question tests recognition of allergic reactions to medications and appropriate nursing response when a contraindicated drug has been administered. The client has a documented sulfonamide allergy and is now experiencing urticaria (hives) after receiving trimethoprim-sulfamethoxazole, which contains a sulfonamide component. Holding the medication and notifying the registered nurse immediately (A) is the priority action to prevent progression to a more severe allergic reaction. Documenting and reassessing in 1 hour (B) delays necessary intervention when an allergic reaction is occurring. Administering the next dose with food (C) is dangerous as it continues exposure to the allergen. Requesting a different antibiotic (D) is appropriate but not the immediate priority when an active allergic reaction is present. The principle of prioritization in adverse reactions is to stop the offending agent immediately and seek appropriate help. A transferable strategy is to always verify allergies before administration and recognize that any new symptoms after starting a medication could indicate an adverse reaction requiring immediate action.

This question tests recognition of pulmonary toxicity as a serious adverse effect of nitrofurantoin, especially in clients with renal impairment. The client's elevated creatinine (2.3 mg/dL) indicates significant kidney disease, which increases the risk of nitrofurantoin accumulation and toxicity. New shortness of breath or persistent cough (A) could indicate pulmonary fibrosis or pneumonitis, serious adverse effects of nitrofurantoin requiring immediate medical attention. Darker yellow urine (B) is an expected harmless effect of nitrofurantoin. Mild loss of appetite (C) is a minor side effect not requiring immediate reporting. Headache relieved by rest (D) is not concerning if self-limiting. The principle of adverse effect monitoring is that respiratory symptoms with nitrofurantoin require immediate evaluation due to potential for irreversible lung damage. A transferable strategy is to recognize that clients with renal impairment are at higher risk for drug toxicity and require closer monitoring for serious adverse effects.

This question tests recognition of cross-reactivity between penicillin and other beta-lactam antibiotics requiring medication reconciliation. The client has a history of anaphylaxis to penicillin, and amoxicillin is a penicillin-type antibiotic with high cross-reactivity risk. Questioning the amoxicillin order (A) is appropriate because clients with penicillin anaphylaxis should not receive penicillin derivatives. Acetaminophen (B) is safe and has no cross-reactivity with penicillin. Normal saline nasal spray (C) is a safe symptomatic treatment. Increasing oral fluids (D) is a supportive measure with no allergy concerns. The principle of medication safety is that documented severe allergies must be respected, and cross-reactive medications avoided. A transferable strategy is to recognize that penicillin allergy extends to all penicillin derivatives (amoxicillin, ampicillin) and requires careful consideration of alternative antibiotics.

This question tests prioritization of clients experiencing medication-related adverse effects using the ABCs (airway, breathing, circulation) framework. Client 1 is experiencing signs of anaphylaxis (wheezing, facial flushing) with hypoxemia (oxygen saturation 89%) after receiving ceftriaxone, indicating respiratory compromise. Client 1 with wheezing and low oxygen saturation (C) requires immediate intervention due to airway/breathing compromise. Client 2's mild nausea (A) is a common side effect of metformin that doesn't require urgent intervention. Client 4's drowsiness (B) is an expected effect of diphenhydramine with stable respirations. Client 3's increased urination (D) is the expected therapeutic effect of furosemide with acceptable potassium level. The principle of prioritization is that respiratory compromise always takes precedence over expected side effects or therapeutic responses. A transferable strategy is to use ABC prioritization and recognize that beta-lactam antibiotics like ceftriaxone can cause immediate hypersensitivity reactions requiring emergency intervention.

This question tests recognition of medication allergy documentation and the nurse's responsibility to prevent allergic reactions. The client has a documented allergy to azithromycin with a previous reaction of hives, and the same medication has been ordered. Holding the dose and notifying the registered nurse (B) is the priority to prevent re-exposure to a known allergen that previously caused an allergic reaction. Administering the medication (A) violates the principle of allergy avoidance and could cause a severe reaction. Asking if the client is willing to take it (C) is inappropriate as it puts the client at risk. Giving with food (D) doesn't prevent allergic reactions. The principle of medication safety is that documented allergies must be strictly observed, and the nurse has a duty to advocate for safe medication administration. A transferable strategy is to always verify allergies before administration and recognize that the nurse must refuse to give medications to which the client has documented allergies.

This question tests recognition of a serious drug interaction between warfarin and trimethoprim-sulfamethoxazole resulting in excessive anticoagulation. The client's INR of 5.2 is critically elevated (therapeutic range typically 2-3), and he's showing signs of bleeding including bleeding gums and melena (dark, tarry stools). Holding warfarin and notifying the registered nurse immediately (B) is the priority to prevent further bleeding complications. Teaching about bleeding precautions (A) is important but not the immediate priority when active bleeding is occurring. Administering the next dose (C) would worsen the bleeding risk. Rechecking the INR later (D) delays necessary intervention for a critical value. The principle of prioritization is that active bleeding with supratherapeutic anticoagulation requires immediate intervention. A transferable strategy is to recognize that antibiotics, especially sulfonamides, can potentiate warfarin's effects and require close INR monitoring.

Chest tightness and generalized pruritus (itching) developing within minutes of starting an IV antibiotic are early indicators of a potentially life-threatening hypersensitivity reaction or anaphylaxis. The immediate priority is to stop the infusion — removing ongoing exposure to the suspected allergen — before taking any other action. Additional subsequent steps include notifying the PHCP (not only the charge nurse), assessing vital signs, maintaining IV access with normal saline, and preparing for emergency interventions such as epinephrine and oxygen if the reaction progresses. Increasing the infusion rate (A) would accelerate allergen delivery and worsen the reaction. Giving an oral antihistamine (C) is not the first action for a potentially life-threatening reaction and does not address the ongoing allergen exposure. Documenting and monitoring without intervening (D) allows the reaction to progress unchecked.

New bruising in unusual locations and spontaneous gum bleeding are clinical cues of excessive anticoagulation — a significant adverse effect of anticoagulant therapy that increases the risk of serious or fatal hemorrhage. The nurse must withhold the next dose, obtain coagulation studies (INR/PT), and notify the PHCP promptly. Anticoagulation does not cause bruising and bleeding as a therapeutic response (A) — these are signs of excessive effect, not optimal effect. The findings describe systemic bleeding manifestations, not a localized allergic reaction (B), which would typically present as rash, hives, or pruritus. Multiple bleeding sites and abnormal bruising indicate excessive anticoagulation (too high), not insufficient dosing (D).

Angioedema — rapid swelling of the face, lips, tongue, or throat — is a rare but potentially life-threatening adverse effect of ACE inhibitors that requires immediate emergency evaluation. It results from ACE inhibitor-induced accumulation of bradykinin, which can cause dangerous airway compromise. This is the most critical safety information to reinforce. Regarding Choice A: a persistent dry cough does affect 10 to 15% of clients on ACE inhibitors (also mediated by bradykinin accumulation) and is a legitimate adverse effect. However, framing it as simply 'normal' is misleading — clients should report it to their provider, as persistent cough may warrant switching to an ARB. A significant increase in heart rate (C) is not an expected effect of ACE inhibitors. Dry, flaky skin (D) is not a recognized ACE inhibitor adverse effect.